ASPE insider filings

Aspen Neuroscience, Inc. — 21 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-09. Screen ASPE transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 21 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
ARCH Venture Fund X, L.P. — 10% owner & ARCH Venture Fund X Overage, L.P. — 10% owner & ARCH Venture Partners X, L.P. — 10% owner & ARCH Venture Partners X Overage, L.P. — 10% owner & ARCH Venture Partners X, LLC — 10% owner & CRANDELL KEITH — 10% owner & Burow Kristina — 10% owner & GILLIS STEVEN — 10% owner & NELSEN ROBERT — 10% owner23 legs · 1,333,333 sh · $19,999,995—18
ARCH Venture Partners XIV, L.P. — 10% owner & ARCH Venture Partners XIV, LLC — 10% owner & ARCH Venture Fund XIV, L.P. — 10% owner & BERNS PAUL L — 10% owner11 leg · 1,200,000 sh · $18,000,000——
ORBIMED ADVISORS LLC — Director, 10% owner & OrbiMed Capital GP VII LLC — Director, 10% owner21 leg · 1,000,000 sh · $15,000,000—10
Thompson Peter A. — Director, 10% owner21 leg · 1,000,000 sh · $15,000,000—10
Hasnain Faheem — Executive Chair, Director3——7
Spaventa Andrew — Director2——4
Boerneke Jeffrey Lee — General Counsel and Secretary1———
Daniel Thomas O — Director1———
Fisher Douglas Carl — Director1———
Johnson-Pratt Lisa — Chief Commercial Officer1———

+5 more insiders in the window, not shown — every filing appears in the table below.

Recent insider filings — Aspen Neuroscience, Inc.

FiledFormInsiderReported transactionsSource
2026-11-094Hasnain Faheem — Executive Chair, DirectorGrant/award (A): 321,672 @ $0EDGAR
2026-11-044Thompson Peter A. — Director, 10% ownerConversion (C): 196,541 · Conversion (C): 642,745 · Conversion (C): 616,984 · Conversion (C): 625,743 · Conversion (C): 507,119 · Purchase (P): 1,000,000 @ $15 · +5 moreEDGAR
2026-11-044ORBIMED ADVISORS LLC — Director, 10% owner
OrbiMed Capital GP VII LLC — Director, 10% owner
Conversion (C): 196,541 · Conversion (C): 642,745 · Conversion (C): 616,984 · Conversion (C): 625,743 · Conversion (C): 507,119 · Purchase (P): 1,000,000 @ $15 · +5 moreEDGAR
2026-11-024ARCH Venture Fund X, L.P. — 10% owner
ARCH Venture Fund X Overage, L.P. — 10% owner
ARCH Venture Partners X, L.P. — 10% owner
ARCH Venture Partners X Overage, L.P. — 10% owner
ARCH Venture Partners X, LLC — 10% owner
CRANDELL KEITH — 10% owner
Burow Kristina — 10% owner
GILLIS STEVEN — 10% owner
NELSEN ROBERT — 10% owner
Purchase (P): 66,666 @ $15 · Conversion (C): 187,182 · Conversion (C): 298,258 · Conversion (C): 286,304 · Conversion (C): 295,490 · Conversion (C): 259,948 · +15 moreEDGAR
2026-11-024ARCH Venture Partners XIV, L.P. — 10% owner
ARCH Venture Partners XIV, LLC — 10% owner
ARCH Venture Fund XIV, L.P. — 10% owner
BERNS PAUL L — 10% owner
Purchase (P): 1,200,000 @ $15EDGAR
2026-11-024Spaventa Andrew — DirectorConversion (C): 70,194 · Conversion (C): 180,221 · Conversion (C): 70,194 (derivative) · Conversion (C): 180,221 (derivative)EDGAR
2026-11-024Hasnain Faheem — Executive Chair, DirectorConversion (C): 14,913 · Conversion (C): 14,316 · Conversion (C): 7,120 · Conversion (C): 14,913 (derivative) · Conversion (C): 14,316 (derivative) · Conversion (C): 7,120 (derivative)EDGAR
2026-10-293ORBIMED ADVISORS LLC — Director, 10% owner
OrbiMed Capital GP VII LLC — Director, 10% owner
Holdings only — no transactions reportedEDGAR
2026-10-293Boerneke Jeffrey Lee — General Counsel and SecretaryHoldings only — no transactions reportedEDGAR
2026-10-293Spaventa Andrew — DirectorHoldings only — no transactions reportedEDGAR
2026-10-293Hasnain Faheem — Executive Chair, DirectorHoldings only — no transactions reportedEDGAR
2026-10-293Daniel Thomas O — DirectorHoldings only — no transactions reportedEDGAR
2026-10-293ARCH Venture Fund X, L.P. — 10% owner
ARCH Venture Fund X Overage, L.P. — 10% owner
ARCH Venture Partners X, L.P. — 10% owner
ARCH Venture Partners X Overage, L.P. — 10% owner
ARCH Venture Partners X, LLC — 10% owner
CRANDELL KEITH — 10% owner
Burow Kristina — 10% owner
GILLIS STEVEN — 10% owner
NELSEN ROBERT — 10% owner
Holdings only — no transactions reportedEDGAR
2026-10-293Thompson Peter A. — Director, 10% ownerHoldings only — no transactions reportedEDGAR
2026-10-293McDevitt Damien — See Remarks, DirectorHoldings only — no transactions reportedEDGAR
2026-10-293Fisher Douglas Carl — DirectorHoldings only — no transactions reportedEDGAR
2026-10-293Peterson Caryn — DirectorHoldings only — no transactions reportedEDGAR
2026-10-293Meeter Dalen — Chief Financial OfficerHoldings only — no transactions reportedEDGAR
2026-10-293Johnson-Pratt Lisa — Chief Commercial OfficerHoldings only — no transactions reportedEDGAR
2026-10-293Raineri Kim — Chief Technology OfficerHoldings only — no transactions reportedEDGAR
2026-10-293Perettie Cynthia Dorothy — DirectorHoldings only — no transactions reportedEDGAR

Recent 8-K events — Aspen Neuroscience, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-028-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR

Registration filings — Aspen Neuroscience, Inc.

Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ASPE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs